In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement specifics including the famous article 71, which allows an early paid access.
Who else could better speak about the Swiss system with him than Remo Christen? Remo is working since > 20 years in the Swiss market access environment in a leading role at Roche’s Swiss affiliate.
In this episode, listeners will learn the specifics of the Swiss culture, the reimbursement process also in comparison to the German AMNOG and why Switzerland is attractive for drug launches.
MAP – Market Access Podcast, is the first and only bi-weekly market access podcast provided by MArS. Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website
For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
Episode 3 – October 1, 2021